Literature DB >> 33521319

COVID-19 vaccine: Call for employees in international transportation industries and international travelers as the first priority in global distribution.

Zhuo Yu1, Gang Wang2, Emanuel Goldman3, Barbara Zangerl4, Ning Xie5, Yanhong Cao6, Jingyu Chen7, Sara W Day8, Scott C Howard8, Marcello Maida9, Kunal Ray10, Monica M Jablonski11, Jiafu Ji12, Arnold Postlethwaite13,14, Weikuan Gu14,15, Dianjun Sun6, Lotfi Aleya16.   

Abstract

While countries are in a hurry to obtain SARS-CoV-2 vaccine, we are concerned with the availability of vaccine and whether a vaccine will be available to all in need. We predicted three possible scenarios for vaccine distributions and urge an international united action on the worldwide equitable access. In case the international community does not reach a consensus on how to distribute the vaccine to achieve worldwide equitable access, we call for a distribution plan that includes the employees in international transportation industries and international travelers to halt the disease transmission and promote the recovery of the global economy.
© 2021 Zhuo Yu et al., published by De Gruyter.

Entities:  

Keywords:  COVID-19; international collaboration; international transportation; priority; vaccine

Year:  2021        PMID: 33521319      PMCID: PMC7811367          DOI: 10.1515/med-2021-0210

Source DB:  PubMed          Journal:  Open Med (Wars)


  13 in total

1.  How the pandemic might play out in 2021 and beyond.

Authors:  Megan Scudellari
Journal:  Nature       Date:  2020-08       Impact factor: 49.962

2.  Fairly Prioritizing Groups for Access to COVID-19 Vaccines.

Authors:  Govind Persad; Monica E Peek; Ezekiel J Emanuel
Journal:  JAMA       Date:  2020-10-27       Impact factor: 56.272

3.  Managing uncertainty during a global pandemic: An international business perspective.

Authors:  Piyush Sharma; T Y Leung; Russel P J Kingshott; Nebojsa S Davcik; Silvio Cardinali
Journal:  J Bus Res       Date:  2020-05-25

4.  Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series.

Authors:  Merle M Böhmer; Udo Buchholz; Victor M Corman; Martin Hoch; Katharina Katz; Durdica V Marosevic; Stefanie Böhm; Tom Woudenberg; Nikolaus Ackermann; Regina Konrad; Ute Eberle; Bianca Treis; Alexandra Dangel; Katja Bengs; Volker Fingerle; Anja Berger; Stefan Hörmansdorfer; Siegfried Ippisch; Bernd Wicklein; Andreas Grahl; Kirsten Pörtner; Nadine Muller; Nadine Zeitlmann; T Sonia Boender; Wei Cai; Andreas Reich; Maria An der Heiden; Ute Rexroth; Osamah Hamouda; Julia Schneider; Talitha Veith; Barbara Mühlemann; Roman Wölfel; Markus Antwerpen; Mathias Walter; Ulrike Protzer; Bernhard Liebl; Walter Haas; Andreas Sing; Christian Drosten; Andreas Zapf
Journal:  Lancet Infect Dis       Date:  2020-05-15       Impact factor: 25.071

5.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

6.  Covid-19 - Navigating the Uncharted.

Authors:  Anthony S Fauci; H Clifford Lane; Robert R Redfield
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

7.  Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.

Authors:  Cheryl Keech; Gary Albert; Iksung Cho; Andreana Robertson; Patricia Reed; Susan Neal; Joyce S Plested; Mingzhu Zhu; Shane Cloney-Clark; Haixia Zhou; Gale Smith; Nita Patel; Matthew B Frieman; Robert E Haupt; James Logue; Marisa McGrath; Stuart Weston; Pedro A Piedra; Chinar Desai; Kathleen Callahan; Maggie Lewis; Patricia Price-Abbott; Neil Formica; Vivek Shinde; Louis Fries; Jason D Lickliter; Paul Griffin; Bethanie Wilkinson; Gregory M Glenn
Journal:  N Engl J Med       Date:  2020-09-02       Impact factor: 91.245

8.  COVID-19 vaccines: early success and remaining challenges.

Authors:  Naor Bar-Zeev; Tom Inglesby
Journal:  Lancet       Date:  2020-09-04       Impact factor: 79.321

9.  Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access.

Authors:  Alexandra L Phelan; Mark Eccleston-Turner; Michelle Rourke; Allan Maleche; Chenguang Wang
Journal:  Lancet       Date:  2020-09-07       Impact factor: 79.321

Review 10.  The recent challenges of highly contagious COVID-19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy.

Authors:  Ranjan K Mohapatra; Lucia Pintilie; Venkataramana Kandi; Ashish K Sarangi; Debadutta Das; Raghaba Sahu; Lina Perekhoda
Journal:  Chem Biol Drug Des       Date:  2020-07-26       Impact factor: 2.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.